IV doses of 25-400 mcg/kg for safety studies Important: These are experimental doses used in animal studies and cannot be extrapolated to other species due to significant differences in metabolism, pharmacokinetics, receptor expression, peptide degradation rates, and tissue distribution patterns
Safety: Its important to note that while AOD-9604 demonstrated excellent safety and tolerability, the clinical development program was ultimately discontinued because efficacy for weight loss did not meet regulatory approval standards
Typical protocols: Research protocols typically use 250-500mcg of BPC-157 once or twice daily
These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease
The type depends on which globin chain is affected
Extracellular signaling molecules